Begin Your Treatment This Week For many patients, yes GLP-1 medications like semaglutide and tirzepatide now produce weight loss results (1525% of total body weight) that approach what was previously only achievable with weight loss surgery
Branded options like Ozempic, Wegovy, and Mounjaro are FDA-approved and manufactured by pharmaceutical companies under Good Manufacturing Practice standards
The Phase 2 VISTA trial demonstrated that Elecoglipron (AZD5004), a once-daily oral small-molecule GLP-1 receptor agonist, achieved up to 11.8% mean weight loss at 36 weeks in adults with obesity or overweight without diabetes
Richardson is dedicated to providing personalized and effective care for her patients
Regular communication with healthcare providers and support systems helps ensure optimal treatment results
Comparative studies among different weight loss surgery methods indicate that sleeve gastrectomy (SG) results in an even more significant elevation in GLP-2 levels, doubling those observed in the sham surgery control group [21]
